Adaptimmune Therapeutics Plc Defensive Interval Ratio
Adaptimmune Therapeutics Plc defensive interval ratio. Adaptimmune Therapeutics Plc (ADAP) has a Defensive Interval Ratio of 205 days as of June 2025. Defensive assets of $28.89 Million (cash $-, short-term investments $0.00, receivables $28.89 Million) cover 205 days of daily cash needs of $141.13K/day. See Adaptimmune Therapeutics Plc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Adaptimmune Therapeutics Plc (2011–2024)
Defensive interval ratio of Adaptimmune Therapeutics Plc from 2011 to 2024. This chart shows how Adaptimmune Therapeutics Plc's Defensive Interval Ratio has evolved across 14 annual periods from 2011 to 2024. As of June 2025, the ratio stands at 205 days, meaning defensive assets of $28.89 Million can fund 205 days of operations without new revenue. Check ADAP asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Adaptimmune Therapeutics Plc Defensive Interval Ratio by Year (2011–2024)
Adaptimmune Therapeutics Plc defensive interval ratio by year from 2011 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Adaptimmune Therapeutics Plc from 2011 to 2024, covering 14 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Adaptimmune Therapeutics Plc assets under control.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 432 days | $76.45 Million | $176.79K/day | $- | $60.47 Million | ▲ +182 days |
| 2023 | 250 days | $49.87 Million | $199.42K/day | $- | $2.95 Million | ▼ -512 days |
| 2022 | 762 days | $134.66 Million | $176.72K/day | $- | $96.57 Million | ▼ -718 days |
| 2021 | 1480 days | $253.64 Million | $171.35K/day | $- | $219.63 Million | ▼ -1622 days |
| 2020 | 3102 days | $332.06 Million | $107.05K/day | $- | $311.33 Million | ▲ +2481 days |
| 2019 | 621 days | $58.41 Million | $94.08K/day | $- | $39.13 Million | ▼ -1670 days |
| 2018 | 2291 days | $153.41 Million | $66.95K/day | $- | $136.75 Million | ▲ +1624 days |
| 2017 | 667 days | $135.88 Million | $203.60K/day | $- | $124.22 Million | ▲ +392 days |
| 2016 | 276 days | $30.42 Million | $110.33K/day | $- | $22.69 Million | ▼ -553 days |
| 2015 | 829 days | $60.74 Million | $73.31K/day | $- | $55.30 Million | ▲ +0 days |
| 2014 | 829 days | $60.74 Million | $73.31K/day | $- | $55.30 Million | ▲ +450 days |
| 2013 | 378 days | $55.00 Million | $145.50K/day | $- | $55.00 Million | ▲ +376 days |
| 2012 | 3 days | $27.37K | $10.87K/day | $- | $- | ▼ -58 days |
| 2011 | 61 days | $680.11K | $11.21K/day | $- | $- | — |